Piedmont Capital Investments

Piedmont Capital Investments is a venture capital firm established in 2020 and located in Raleigh, North Carolina. The firm specializes in investing in transformative companies within the science and technology sectors. By focusing on innovative and impactful businesses, Piedmont Capital Investments aims to support the growth and development of ventures that have the potential to make significant contributions to their respective industries.

Robert Long

Co-Founder, General Partner and Manager

12 past transactions

Scout AI

Seed Round in 2025
Scout AI specializes in developing AI-driven autonomous control systems tailored for military applications. Their core product is a modular, end-to-end mission autonomy operating system, which enables a range of unmanned ground missions. This technology allows military forces to deploy attritable drones with minimal risk to human soldiers, thereby freeing them up for more complex tasks.

MetOx Technologies

Series B in 2023
MetOx Technologies is a manufacturer specializing in high-temperature superconducting (HTS) wire, utilizing YBCO to achieve efficient electricity transmission. This innovative wire transmits large amounts of electricity with minimal cross-sectional area, eliminating electrical loss and heat generation during operation. MetOx employs a proprietary one-pass metal-organic chemical vapor deposition process for producing both buffer and high-temperature superconductor layers. The applications of its HTS wire are diverse, impacting sectors such as transmission and distribution of electricity, magnetic confinement fusion reactors, wind energy, and advanced MRI scanners. By enhancing the quality and cost-effectiveness of HTS wire, MetOx Technologies supports advancements in energy efficiency and technology development across multiple industries.

nZero

Series A in 2023
Nzero is a carbon emissions tracking management platform established in 2017 and based in Carson City, Nevada. The company specializes in capturing accurate data on Scope 1, 2, and 3 emissions by utilizing customers' energy, water, and utility data, along with publicly-reported emissions and partner information. Its platform delivers actionable and auditable insights that assist organizations in reducing their carbon footprint and achieving net-zero goals. In addition to emissions tracking, Nzero's platform supports financial reporting, contract administration, and decision-making processes, facilitating compliance with regulatory and legal requirements while promoting sustainability efforts.

Pryon

Venture Round in 2022
Pryon Inc. is an artificial intelligence company based in Raleigh, North Carolina, founded in 2017. It specializes in enterprise knowledge management through its augmented intelligence platform, which effectively combines human capabilities with machine intelligence. The platform enhances productivity by transforming unstructured data into actionable insights, utilizing advanced techniques such as natural language processing and automated machine learning. By providing context-aware access to knowledge and streamlining workflows, Pryon enables organizations to reduce complexity and operational costs while maximizing the value of their information assets. The company was established by Igor Jablokov, who previously developed AI assistants that contributed to the foundation of Alexa.

Tavros Therapeutics

Seed Round in 2022
Tavros Therapeutics is a biotechnology company based in Durham, North Carolina, focused on discovering and developing therapies for cancer. Founded in 2019, the company aims to advance oncology treatments by identifying vulnerabilities within tumors. This approach allows for targeted drug combinations, potentially improving outcomes for patients with oncological diseases.

Epirus

Series C in 2022
Epirus, Inc. is a technology company based in Hawthorne, California, specializing in the design and development of advanced defense systems that utilize artificial intelligence and directed energy. Founded in 2018, the company focuses on creating solid-state, software-defined high-power microwave solutions aimed at countering unmanned aircraft systems and other asymmetric threats. Its flagship product, ELECTROMAGNETIC PULSE, serves as a counter-infrastructure solution that can simultaneously target multiple threats, effectively neutralizing drones and swarms. By integrating AI and machine learning with advanced electronics, Epirus enhances the detection and tracking of objects of interest, offering innovative capabilities in electronic warfare and power management for both defense and commercial sectors.

Posh

Series A in 2021
Posh is a conversational AI and NLP technology development company that enables developers to deliver a new way to interact with users. With Posh, website actions that takes minutes to complete can be sped up to just seconds with a simple message from bots. Companies in finanical services, healthcare, utilities, and beyond are using the Posh platform to re-create call centers and automate routine requests for both customers and staff while saving time and money. The company wants to make the internet experience easier and more enjoyable. Posh was launched on 2015 and is based in Boston, Massachusetts.

Immunai

Series B in 2021
Immunai Inc. is a biotechnology company that specializes in developing an artificial intelligence-based immune profiling platform aimed at enhancing drug development and improving disease detection, diagnosis, and treatment. The company utilizes single-cell genomics and machine learning algorithms to conduct high-resolution profiling of the immune system, generating valuable biological insights that facilitate research and development. Immunai's platform focuses on biomarker discovery, enabling the identification of how immune cells respond to various conditions, and supports the development of therapies for oncology and autoimmune disorders. Established in 2018 and headquartered in New York City, Immunai also maintains offices in San Francisco and Tel Aviv, collaborating with academic institutions, biopharmaceutical firms, and biotechnology companies to advance its mission of mapping the immune system and its functions.

Tvardi Therapeutics

Series B in 2021
Tvardi Therapeutics, Inc. is a biotechnology company based in Houston, Texas, dedicated to developing innovative treatments for cancer, chronic inflammation, and fibrosis. Founded in 2017, the company specializes in the development of small-molecule inhibitors targeting STAT3, a protein that plays a crucial role in the survival, immune evasion, and progression of various cancers and fibrotic conditions. Tvardi's pipeline includes several candidates, such as TTI-101 in both oral and intravenous formulations, and TTI-102, which shows promise in inhibiting STAT3. The company's focus on these therapeutic areas aims to provide effective solutions for patients suffering from a range of serious health issues.

Epirus

Series B in 2020
Epirus, Inc. is a technology company based in Hawthorne, California, specializing in the design and development of advanced defense systems that utilize artificial intelligence and directed energy. Founded in 2018, the company focuses on creating solid-state, software-defined high-power microwave solutions aimed at countering unmanned aircraft systems and other asymmetric threats. Its flagship product, ELECTROMAGNETIC PULSE, serves as a counter-infrastructure solution that can simultaneously target multiple threats, effectively neutralizing drones and swarms. By integrating AI and machine learning with advanced electronics, Epirus enhances the detection and tracking of objects of interest, offering innovative capabilities in electronic warfare and power management for both defense and commercial sectors.

Tavros Therapeutics

Seed Round in 2020
Tavros Therapeutics is a biotechnology company based in Durham, North Carolina, focused on discovering and developing therapies for cancer. Founded in 2019, the company aims to advance oncology treatments by identifying vulnerabilities within tumors. This approach allows for targeted drug combinations, potentially improving outcomes for patients with oncological diseases.

Sift Media

Series A in 2016
Sift Media, Inc., based in Durham, North Carolina, specializes in developing automated bidding software for mobile advertisement opportunities within real-time auction exchanges. Founded in 2015, the company utilizes advanced artificial intelligence and machine learning algorithms to optimize mobile advertising campaigns. Sift Media processes over 50 billion mobile ad requests daily, enabling it to hyper-target app install advertisements effectively. Its platform is designed to enhance campaign performance by optimizing conversion rates and click-to-install times, while also providing features for whitelisting and blacklisting specific app bundles. To date, Sift Media has served over 40 billion mobile ads and facilitated more than 25 million app installs for a diverse range of advertisers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.